fbpx
QQQ
-2.19
326.60
-0.68%
DIA
-2.60
346.25
-0.76%
SPY
-3.50
419.02
-0.84%
TLT
-0.35
137.14
-0.26%
GLD
+ 0.33
174.37
+ 0.19%

Analyzing The Price Action In DocuSign Stock Today

April 13, 2021 10:39 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

DocuSign's Stock Price And Volume Action

DocuSign (NASDAQ:DOCU) is currently up 6.51% to a price of $225.7. Tuesday the stock has been traded at a volume of 1.12 million, about 34.39% of its recent 30-day volume average of 3.26 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Shares of software companies are trading higher after the FDA asked US states to pause administration of J&J's COVID-19 vaccine following blood clots in six individuals, which has caused reopening uncertainty. This has driven a rotation back into pandemic plays and work-from-home stocks for the session.

Perspective On Recent Price Action

The 50-day moving average price of DocuSign's stock was $224.61 when this article was published. The stock reached a high of $290.23 and a low of $86.13 in the past 52 weeks.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

60 Biggest Movers From Friday

Gainers NLS Pharmaceutics AG (NASDAQ: NLSP) shares climbed 106.7% to close at $5.85 on Friday in reaction to a License Agreement with Novartis Pharma AG, a unit of Novartis, wherein NLS secured an exclusive license to Sanorex (mazindol) in the U.S. read more

8 Information Technology Stocks Moving In Friday's Intraday Session

  read more

44 Stocks Moving In Friday's Mid-Day Session

Gainers NLS Pharmaceutics AG (NASDAQ: NLSP) shares jumped 87.3% to $5.30 in reaction to a License Agreement with Novartis Pharma AG, a unit of Novartis, wherein NLS secured an exclusive license to Sanorex (mazindol) in the U.S. read more

3 DocuSign Stock Analysts On Q4 Results: Should Investors Buy The Dip?

Shares of DocuSign, Inc. (NASDAQ: DOCU) dipped Thursday afternoon after the eSignature solution company reported fourth-quarter results that disappointed some investors. read more